PRME
NASDAQ · Biotechnology
Prime Medicine Inc
$2.98
+0.17 (+6.05%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+1,349.3% upside
Low Target
$33.60
Average Target
$43.19
High Target
$71.66
Current Price
$2.98
Current
$2.98
$2.98
Target
$43.19
$43.19
$33.60
$43.19 avg
$71.66
Scenario Analysis
Bear Case
$33.60
1,027.5%
Low target
Base Case
$43.19
+1,349.3%
Avg target
Bull Case
$71.66
+2,304.7%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$6.94
-57.1% from high
52-Week Low
$2.67
+11.6% from low
Target vs 52W High
$43.19
+522.3% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |